Table 5. | Characteristics of the included studies |
Study |
Patients (n) |
Sockets (n) |
Smoking patients | IS pathology |
Age (years) |
Site |
Follow-up (months) |
Implant system |
---|---|---|---|---|---|---|---|---|
Montoya-Salazar et al. [18] | 18 | 36 (IS:18, NIS:18 | Included | Chronic periapical lesion | 18 - 50 | Incisors, canines and premolars | 36 | MIS C1 implants (MIS Implants Technologies Ltd.; Tel Aviv, Israel) |
Jung et al. [19] | 27 | 27 (IS:12, NIS:15) | Included | Periapical pathologies | 31 - 87 (IS) 28 - 82 (NIS) | Incisors, canines and premolars | 60 | Straumann® Standard Plus or Tapered Effect (Straumann AG; Basal, Switzerland) |
Crespi et al. [20] | 37 | 275 (IS:197, NIS:78) |
Heavy smokers excluded (> 10 cigarettes/day) |
Chronic periodontal lesions | 32 - 71 | Incisors, canines and premolars | 48 | Sweden and Martina SPA, Due Carrare, Padova, Italy |
Crespi et al. [21] | 30 | 30 (IS:15, NIS:15) |
Heavy smokers excluded (> 10 cigarettes/day) |
Periapical lesions and radiolucencies | 34 - 71 | Incisors, canines and premolars | 24 | Seven (Sweden and Martina SPA, Due Carrare, Padova, Italy) |
Hita-Iglesias et al. [22] | 60 | 168 (IS:66, NIS:102) | Non-smokers only | Chronic periapical lesions | 18 - 72 | Incisors, canines and premolars | 12 | Zimmer dental, USA |
Blus et al. [23] | 86 | 168 (IS:83, NIS:85) | No data | Acute and chronic infection | 26 - 77 | Incisors, canines and premolars | 12 | Leader Implants; Milan, Italy or and Bioner Sistemas Implantológicos, Barcelona, Spain |
Bell et al. [24] | 655 | 922 (IS:285, NIS:637) | Included | Chronic periapical lesion | Mean: 58.4 IS; 60.1 NIS | Incisors, canines, premolars and molars | 3 - 93 | Straumann® Tissue Level or Bone Level SLA (Straumann AG; Basal, Switzerland) |
Fugazzotto [25] | 64 | 128 (IS:64, NIS:64) |
Heavy smokers excluded (> 10 cigarettes/day) |
Periapical pathologies | 21 - 71 | Incisors | 24 - 117 | No data |
Zuffetti et al. [26] | 369 | 527 (IS:193, NIS:334) |
Heavy smokers included (> 10 cigarettes/day) |
Chronic infection | 22.8 - 81.9 | Incisors, canines, premolars and molars | Mean 52.1 |
BIOMET 3i® (BIOMET 3i LLC; Palm Beach Gardens, Florida, USA).
Biohorizons® (BioHorizons Inc; Birmingham, Alabama, USA). Nobel Biocare AG; Zürich, Switzerland. Astra Tech Implant System™ (Dentsply Sirona; Göteborg/Mölndal, Sweden). MegaGen Implant Co. Limited; Gyeong-buk, South Korea. Neoss AB; Göteborg, Sweden. |
n = numbers; IS = infected socket; NIS = non-infected socket; ASA = The American Society of Anaesthesiologists physical status classification system. |